Verrica Pharmaceuticals Inc (VRCA) - Total Liabilities

Latest as of December 2025: $22.39 Million USD

Based on the latest financial reports, Verrica Pharmaceuticals Inc (VRCA) has total liabilities worth $22.39 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Verrica Pharmaceuticals Inc generate cash to assess how effectively this company generates cash.

Verrica Pharmaceuticals Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how Verrica Pharmaceuticals Inc's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Verrica Pharmaceuticals Inc to evaluate the company's liquid asset resilience ratio.

Verrica Pharmaceuticals Inc Competitors by Total Liabilities

The table below lists competitors of Verrica Pharmaceuticals Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Daldrup & Söhne Aktiengesellschaft F:4DS	Germany	€11.69 Million
Balyo SA PA:BALYO	France	€34.75 Million
Taiwan Line Tek Electronic Co Ltd TW:2462	Taiwan	NT$2.74 Billion
Nava Nakorn Public Company Limited BK:NNCL	Thailand	฿1.09 Billion
Sona Topas Tourism Industry JK:SONA	Indonesia	Rp280.21 Billion
Aztek Teknoloji Urunleri Ticaret A.S. IS:AZTEK	Turkey	TL2.90 Billion
T.A.C. Consumer Public Company Limited BK:TACC	Thailand	฿479.12 Million
Yong Pyong Resort Corp KO:070960	Korea	₩625.21 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Verrica Pharmaceuticals Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Verrica Pharmaceuticals Inc market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.59	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.90	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Verrica Pharmaceuticals Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Verrica Pharmaceuticals Inc (2016–2025)

The table below shows the annual total liabilities of Verrica Pharmaceuticals Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	$22.39 Million	-65.02%
2024-12-31	$63.99 Million	+3.49%
2023-12-31	$61.83 Million	+1218.98%
2022-12-31	$4.69 Million	-90.13%
2021-12-31	$47.52 Million	+15.43%
2020-12-31	$41.17 Million	+1107.63%
2019-12-31	$3.41 Million	+37.63%
2018-12-31	$2.48 Million	-84.64%
2017-12-31	$16.12 Million	+402.62%
2016-12-31	$3.21 Million	--

About Verrica Pharmaceuticals Inc

NASDAQ:VRCA USA Biotechnology

Market Cap

$107.71 Million

Market Cap Rank

#19180 Global

#4211 in USA

Share Price

$6.27

Change (1 day)

-1.57%

52-Week Range

$0.41 - $9.10

All Time High

$20.34